UK Receives £1bn Confidence Boost From Industry Investment In Life Sciences Sector
The international biopharma industry is backing the UK life sciences sector, with UCB spearheading the charge with a £1bn commitment to R&D in the nation still in a state of flux regarding its exit from the European Union in 2019.